Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
The net effect is therefore best treated as an empirical question, not a settled mechanismconsistent with the comparative observational findings summarised below
Eli Lillys GLP-1 Trulicity ($7.1 BB and dual GLP-1/GIP Mounjaro ($5.2 B) also surged
Absorption Clinicians administer GLP-1 receptor agonists, such as Exenatide, Liraglutide, and Semaglutide, for rapid absorption and peak plasma concentrations within hours (16)(23)
While some telehealth services prescribe GLP-1 medications, we recommend in-person care at a weight loss clinic like ours
Regarding its properties, Norethindrone Acetate is known for its effective oral absorption and long-lasting presence in the body, making it suitable for once-a-day dosing in different treatment plans
